XML 77 R27.htm IDEA: XBRL DOCUMENT v2.4.1.9
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Assumptions Used to Compute Share-Based Compensation Costs for Stock Options Granted

The assumptions used to compute the share-based compensation costs for the stock options granted during the years ended December 31, 2014, 2013 and 2012, respectively, using the Black-Scholes option pricing model, were as follows:

 

     Year Ended December 31,  
     2014     2013     2012  

Weighted average grant-date fair value of stock options

   $ 0.57      $ 0.63      $ 0.80   

Assumptions

      

Risk-free interest rate (weighted average)

     1.2     0.6     0.5

Expected dividend yield

     —          —          —     

Weighted average expected life (years)

     4        4        4   

Volatility (weighted average)

     82.9     68.1     80.0

Forfeiture rate

     25.5     11.4     13.7
Assumptions Used Estimate Fair Value of Employee Stock Purchase Plans

Following is a schedule of the shares purchased, the fair value per share, and the Black-Scholes model assumptions for each offering period:

 

     (Ending)              
Offering Period Ended    March 31,     September 30,     March 31,     September 30,     March 31,  
     2015     2014     2014     2013     2013  

Shares purchased for offering period

       13,619        13,734        19,490        18,594   

Fair value per share

   $ 0.43      $ 0.83      $ 0.30      $ 0.44      $ 0.65   

Assumptions

          

Risk-free interest rate (average)

     0.40     0.80     0.40     0.11     0.14

Expected dividend yield

     —          —          —          —          —     

Weighted average expected life (years)

     0.5        0.5        0.5        0.5        0.5   

Volatility (average)

     109.0     74.0     44.0     45.0     74.0
Stock-Based Non-Cash Compensation Expenses

Stock-based non-cash compensation expenses related to stock options, restricted stock grants and the ESPP were recorded in the financial statements as follows (in thousands):

 

     Year Ended December 31,  
     2014      2013      2012  

Cost of revenues

   $ 13       $ 20       $ 13   

Selling and marketing

     270         766         865   

Research and development

     659         809         765   

General and administrative

     1,437         1,938         2,306   

Restructuring expense

     1,273         —           —     
  

 

 

    

 

 

    

 

 

 

Total non-cash stock compensation expense

$ 3,652    $ 3,533    $ 3,949   
  

 

 

    

 

 

    

 

 

 
Summary of Outstanding Stock Options and Related Activity

A summary of the Company’s stock options outstanding under the 2005 Plan as of December 31, 2014 and the activity during the years ended herein are as follows (in thousands except per share amounts):

 

            Weighted Ave.      Aggregate  
     Shares      Exercise Price      Intrinsic Value  

Outstanding as of December 31, 2011

     2,167       $ 11.03       $ —     
  

 

 

       

 

 

 

(2,167 options exercisable at a weighted average exercise price of $11.03)

Granted (weighted average fair value of $0.80)

  826    $ 1.39   

Exercised

  (32 $ 0.50   

Cancelled

  (686 $ 12.37   
  

 

 

       

 

 

 

Outstanding as of December 31, 2012

  2,275    $ 7.02    $ —     
  

 

 

       

 

 

 

(1,474 options exercisable at a weighted average exercise price of $10.09)

Granted (weighted average fair value of $0.63)

  120    $ 1.31   

Exercised

  —      $ —     

Cancelled

  (225 $ 6.52   
  

 

 

       

 

 

 

Outstanding as of December 31, 2013

  2,170    $ 6.76    $ —     
  

 

 

       

 

 

 

(1,573 options exercisable at a weighted average exercise price of $8.81)

Granted (weighted average fair value of $0.57)

  633    $ 0.95   

Exercised

  (4 $ 1.38   

Cancelled

  (665 $ 5.98   
  

 

 

       

 

 

 

Outstanding as of December 31, 2014

  2,134    $ 5.29    $ —     
  

 

 

       

 

 

 

Exercisable as of December 31, 2014

  1,291    $ 8.04    $ —     
  

 

 

       

 

 

 

Vested and expected to vest at December 31, 2014

  1,963    $ 5.66    $ —     
  

 

 

       

 

 

 
Summary of Outstanding Restricted Stock Awards and Related Activity

A summary of the Company’s restricted stock awards outstanding under the 2005 Plan as of December 31, 2014, and the activity during years ended therein, are as follows (in thousands):

 

     Number      Weighted average  
     of shares      grant date fair value  

Unvested at December 31, 2011

     1,355       $ 3.21   
  

 

 

    

Granted

  995    $ 2.64   

Vested

  (611 $ 6.42   

Cancelled and forfeited

  (420 $ 8.73   
  

 

 

    

Unvested at December 31, 2012

  1,319    $ 4.60   
  

 

 

    

Granted

  1,495    $ 1.70   

Vested

  (752 $ 4.43   

Cancelled and forfeited

  (316 $ 3.00   
  

 

 

    

Unvested at December 31, 2013

  1,746    $ 2.48   
  

 

 

    

Granted

  1,625    $ 1.79   

Vested

  (1,442 $ 2.48   

Cancelled and forfeited

  (204 $ 1.79   
  

 

 

    

Unvested at December 31, 2014

  1,725    $ 1.91